secwatch.observer — SEC 8-K summary
======================================

Issuer:     AETHLON MEDICAL INC (AEMD)
CIK:        0000882291
Form:       8-K
Filed at:   2024-12-20T23:59:59+00:00
Accession:  0001683168-24-008868
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aethlon Hemopurifier removes 99% of H5N1 in vitro; monitoring bird flu outbreak
-------------------------------------------------------------------------------

- In vitro study with scaled-down Hemopurifier showed 99% removal of H5N1 virus after 6 hours.
- Device has not yet been used in human patients for H5N1; 38 patients treated for other enveloped viruses.
- Hemopurifier holds FDA breakthrough device designation for life-threatening viruses with no effective treatment.
- Company monitoring cases and engaging with hospitals, California, and FDA on potential use.
- CDC recommends antivirals for H5N1; resistance observed in some hospitalized patients, suggesting need for novel therapies.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/882291/000168316824008868/0001683168-24-008868-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/882291/000168316824008868/aethlon_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-24-008868

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer